Adrenal cortical carcinoma

被引:251
作者
Dackiw, APB
Lee, JE
Gagel, RF
Evans, DB
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Sect Endocrine Tumor Surg, Houston, TX 77033 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Internal Med Specialties, Sect Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77033 USA
关键词
D O I
10.1007/s00268-001-0030-7
中图分类号
R61 [外科手术学];
学科分类号
摘要
Adrenal cortical carcinoma is a rare endocrine tumor for which complete surgical resection is the only potentially curative treatment. Accurate preoperative evaluation (biochemical and radiographic) of the patient who presents with an adrenal mass maximizes the opportunity fur the patient to undergo a complete, margin-negative resection of the primary tumor, which is the most powerful prognostic variable for long-term survival. The response to chemotherapy or mitotane is modest in patients with advanced disease. Hopefully, an improved understanding of the molecular pathogenesis of this challenging tumor will lead to the development of more effective therapies in the future.
引用
收藏
页码:914 / 926
页数:13
相关论文
共 114 条
[1]   UNKNOWN PRIMARY-CARCINOMA - NATURAL-HISTORY AND PROGNOSTIC FACTORS IN 657 CONSECUTIVE PATIENTS [J].
ABBRUZZESE, JL ;
ABBRUZZESE, MC ;
HESS, KR ;
RABER, MN ;
LENZI, R ;
FROST, P .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) :1272-1280
[2]   SERENDIPITOUS ADRENAL MASSES - PREVALENCE, SIGNIFICANCE, AND MANAGEMENT [J].
ABECASSIS, M ;
MCLOUGHLIN, MJ ;
LANGER, B ;
KUDLOW, JE .
AMERICAN JOURNAL OF SURGERY, 1985, 149 (06) :783-788
[3]  
ABRAHAM S, 1999, P AN M AM SOC CLIN, V18, pA191
[4]   Adrenal incidentaloma: An overview of clinical and epidemiological data from the National Italian Study Group [J].
Angeli, A ;
Osella, G ;
Ali, A ;
Terzolo, M .
HORMONE RESEARCH, 1997, 47 (4-6) :279-283
[5]  
Backlin C, 1995, ANTICANCER RES, V15, P2453
[6]   Limitations of size as a criterion in the evaluation of adrenal tumors [J].
Barnett, CC ;
Varma, DG ;
El-Naggar, AK ;
Dackiw, APB ;
Porter, GA ;
Pearson, AS ;
Kudelka, AP ;
Gagel, RF ;
Evans, DB ;
Lee, JE .
SURGERY, 2000, 128 (06) :973-982
[7]   MITOTANE ENHANCES CYTOTOXICITY OF CHEMOTHERAPY IN CELL-LINES EXPRESSING A MULTIDRUG RESISTANCE GENE (MDR-1/P-GLYCOPROTEIN) WHICH IS ALSO EXPRESSED BY ADRENOCORTICAL CARCINOMAS [J].
BATES, SE ;
SHIEH, CY ;
MICKLEY, LA ;
DICHEK, HL ;
GAZDAR, A ;
LORIAUX, DL ;
FOJO, AT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (01) :18-29
[8]   Role of reoperation in recurrence of adrenal cortical carcinoma: Results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma [J].
Bellantone, R ;
Ferrante, A ;
Boscherini, M ;
Lombardi, CP ;
Crucitti, P ;
Crucitti, F ;
Favia, G ;
Borrelli, D ;
Boffi, L ;
Capussotti, L ;
Carbone, G ;
Casaccia, M ;
Cavallaro, A ;
Del Gaudio, A ;
Dettori, G ;
Di Giovanni, V ;
Mazziotti, A ;
Marrano, D ;
Masenti, E ;
Miccoli, P ;
Mosca, F ;
Mussa, A ;
Petronio, R ;
Piat, G ;
Ruberti, U ;
Serio, G ;
Marzano, L .
SURGERY, 1997, 122 (06) :1212-1218
[9]  
Berruti A, 1998, CANCER, V83, P2194, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2194::AID-CNCR19>3.3.CO
[10]  
2-V